...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
【24h】

Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.

机译:普瑞巴林对模型突触的作用:与突触前钙通道α2-δ亚基的结合减少小鼠的神经传递。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pregabalin, ((S)-3-(aminomethyl)-5-methylhexanoic acid, also known as (S)-3-isobutyl GABA, Lyricatrade mark) is approved for treatment of certain types of peripheral neuropathic pain and as an adjunctive therapy for partial seizures of epilepsy both the EU and the USA and also for generalized anxiety disorder in the EU. Though pregabalin binds selectively to the alpha(2)-delta (alpha(2)-delta) auxiliary subunit of voltage-gated calcium channels, the cellular details of pregabalin action are unclear. The high density of alpha(2)-delta in skeletal muscle fibers raises the question of whether pregabalin alters excitation-contraction coupling. We used the mouse soleus neuromuscular junction from mice containing an artificially mutated alpha(2)-delta Type 1 protein (R217A) as a model to examine the effect of pregabalin. Pregabalin reduced nerve-evoked muscle contractions by 16% at a clinically relevant concentration of 10 muM in wildtype mice. When acetylcholine receptors were blocked with curare, pregabalin had no effect on contraction from direct stimulation of muscle, suggesting a lack of drug effects on contraction coupling. Our data are consistent with pregabalin having no effect on striated muscle L-type calcium channel function. However, in mice expressing mutant (R217A) alpha(2)-delta Type 1, there was no significant effect of pregabalin on nerve-evoked muscle contraction. We propose that pregabalin reduces presynaptic neurotransmitter release without altering postsynaptic receptors or contraction coupling and that these effects require high affinity binding to alpha(2)-delta Type 1 auxiliary subunit of presynaptic voltage-gated calcium channels.
机译:普瑞巴林(((S)-3-(氨基甲基)-5-甲基己酸,也称为(S)-3-异丁基GABA,抒情商标))被批准用于治疗某些类型的周围神经性疼痛并作为辅助疗法用于欧盟和美国均发生部分癫痫发作,以及欧盟普遍性焦虑症也有发作。尽管普瑞巴林选择性结合至电压门控钙通道的α(2)-δ(α(2)-δ)辅助亚基,但普瑞巴林作用的细胞细节尚不清楚。骨骼肌纤维中高密度的alpha(2)-三角洲提出了普瑞巴林是否会改变激发-收缩耦合的问题。我们使用小鼠比目鱼神经肌肉接头来自包含人工突变的alpha(2)-delta 1型蛋白(R217A)的小鼠作为模型来检查普瑞巴林的作用。在临床相关浓度为10μM的野生型小鼠中,普瑞巴林可将神经诱发的肌肉收缩降低16%。当乙酰胆碱受体被Curare阻断时,普瑞巴林对直接刺激肌肉的收缩没有作用,这表明缺乏药物对收缩偶联的作用。我们的数据与普瑞巴林对横纹肌L型钙通道功能没有影响一致。但是,在表达突变型(R217A)alpha(2)-delta 1型的小鼠中,普瑞巴林对神经诱发的肌肉收缩没有明显影响。我们建议普瑞巴林减少突触前神经递质释放而不改变突触后受体或收缩耦合,并且这些影响需要高亲和力绑定到突触前电压门控钙通道的α(2)-δ1型辅助亚基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号